Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

HENA, heterogeneous network-based data set for Alzheimer's disease.

Sügis E, Dauvillier J, Leontjeva A, Adler P, Hindie V, Moncion T, Collura V, Daudin R, Loe-Mie Y, Herault Y, Lambert JC, Hermjakob H, Pupko T, Rain JC, Xenarios I, Vilo J, Simonneau M, Peterson H.

Sci Data. 2019 Aug 14;6(1):151. doi: 10.1038/s41597-019-0152-0.

2.

Cnidarian Cell Type Diversity and Regulation Revealed by Whole-Organism Single-Cell RNA-Seq.

Sebé-Pedrós A, Saudemont B, Chomsky E, Plessier F, Mailhé MP, Renno J, Loe-Mie Y, Lifshitz A, Mukamel Z, Schmutz S, Novault S, Steinmetz PRH, Spitz F, Tanay A, Marlow H.

Cell. 2018 May 31;173(6):1520-1534.e20. doi: 10.1016/j.cell.2018.05.019. Epub 2018 May 31.

3.

Two independent modes of chromatin organization revealed by cohesin removal.

Schwarzer W, Abdennur N, Goloborodko A, Pekowska A, Fudenberg G, Loe-Mie Y, Fonseca NA, Huber W, Haering CH, Mirny L, Spitz F.

Nature. 2017 Nov 2;551(7678):51-56. doi: 10.1038/nature24281. Epub 2017 Sep 27.

4.

Somatostatin-IRES-Cre Mice: Between Knockout and Wild-Type?

Viollet C, Simon A, Tolle V, Labarthe A, Grouselle D, Loe-Mie Y, Simonneau M, Martel G, Epelbaum J.

Front Endocrinol (Lausanne). 2017 Jun 19;8:131. doi: 10.3389/fendo.2017.00131. eCollection 2017.

5.

Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factors.

Haziza S, Mohan N, Loe-Mie Y, Lepagnol-Bestel AM, Massou S, Adam MP, Le XL, Viard J, Plancon C, Daudin R, Koebel P, Dorard E, Rose C, Hsieh FJ, Wu CC, Potier B, Herault Y, Sala C, Corvin A, Allinquant B, Chang HC, Treussart F, Simonneau M.

Nat Nanotechnol. 2017 May;12(4):322-328. doi: 10.1038/nnano.2016.260. Epub 2016 Nov 28.

PMID:
27893730
6.

SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.

Loe-Mie Y, Lepagnol-Bestel AM, Maussion G, Doron-Faigenboim A, Imbeaud S, Delacroix H, Aggerbeck L, Pupko T, Gorwood P, Simonneau M, Moalic JM.

Hum Mol Genet. 2010 Jul 15;19(14):2841-57. doi: 10.1093/hmg/ddq184. Epub 2010 May 10.

PMID:
20457675
7.

Primate-accelerated evolutionary genes: novel routes to drug discovery in psychiatric disorders.

Moalic JM, Le Strat Y, Lepagnol-Bestel AM, Ramoz N, Loe-Mie Y, Maussion G, Gorwood P, Simonneau M.

Curr Med Chem. 2010;17(13):1300-16. Review.

PMID:
20166940
8.

DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.

Lepagnol-Bestel AM, Zvara A, Maussion G, Quignon F, Ngimbous B, Ramoz N, Imbeaud S, Loe-Mie Y, Benihoud K, Agier N, Salin PA, Cardona A, Khung-Savatovsky S, Kallunki P, Delabar JM, Puskas LG, Delacroix H, Aggerbeck L, Delezoide AL, Delattre O, Gorwood P, Moalic JM, Simonneau M.

Hum Mol Genet. 2009 Apr 15;18(8):1405-14. doi: 10.1093/hmg/ddp047. Epub 2009 Feb 12.

PMID:
19218269
9.

Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism.

Maussion G, Carayol J, Lepagnol-Bestel AM, Tores F, Loe-Mie Y, Milbreta U, Rousseau F, Fontaine K, Renaud J, Moalic JM, Philippi A, Chedotal A, Gorwood P, Ramoz N, Hager J, Simonneau M.

Hum Mol Genet. 2008 Aug 15;17(16):2541-51. doi: 10.1093/hmg/ddn154. Epub 2008 May 20.

PMID:
18492799

Supplemental Content

Loading ...
Support Center